Published in J Neurosurg on March 01, 2003
Endoscope-assisted microneurosurgery for anterior circulation aneurysms using the angle-type rigid endoscope over a 3-year period. Childs Nerv Syst (2004) 0.82
Is preoperative high-resolution magnetic resonance imaging accurate in predicting neurovascular compression in patients with trigeminal neuralgia? A single-blind study. Neurosurg Rev (2005) 0.79
Compared with the Conventional MR Imaging, Do the Constructive Interference Steady State Sequence and Diffusion Weighted Imaging Aid in the Diagnosis of Lumbar Disc Hernias? Eurasian J Med (2011) 0.75
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol (2013) 3.26
Description and first clinical application of AirWay Scope for tracheal intubation. J Neurosurg Anesthesiol (2006) 2.63
Radiometric analysis of paraclinoid carotid artery aneurysms. J Neurosurg (2002) 2.12
Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res (2010) 2.07
Primary Malignant Lymphoma of the Trigeminal Nerve: Case Report and Literature Review. World Neurosurg (2015) 1.98
Association of neural and physiological responses during voluntary emotion suppression. Neuroimage (2005) 1.91
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer (2010) 1.70
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res (2006) 1.65
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res (2008) 1.58
MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res (2011) 1.57
Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol (2010) 1.54
Role of endothelial nitric oxide and smooth muscle potassium channels in cerebral arteriolar dilation in response to acidosis. Stroke (2002) 1.53
Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells (2010) 1.52
MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis (2011) 1.51
Emergency embolectomy for treatment of acute middle cerebral artery occlusion. J Neurosurg (2007) 1.47
miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res (2012) 1.46
Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer (2008) 1.45
Spinal intradural extramedullary cavernous angioma presenting with superficial siderosis and hydrocephalus: a case report and review of the literature. Intern Med (2014) 1.45
Interstitial deletion of 13q14.13-q32.3 presenting with Arima syndrome and bilateral retinoblastoma. Brain Dev (2010) 1.45
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis (2009) 1.44
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Proposal of a risk-stratification system for the Japanese population based on blood pressure levels: the Ohasama study. Hypertens Res (2008) 1.43
Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res (2006) 1.41
Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors. Circ Res (2007) 1.36
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One (2012) 1.35
Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J Invest Dermatol (2004) 1.33
Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol (2002) 1.29
MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One (2013) 1.27
Dual roles of zygotic and maternal Scribble1 in neural migration and convergent extension movements in zebrafish embryos. Development (2005) 1.26
Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One (2012) 1.26
MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res (2007) 1.25
Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst (2002) 1.24
Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer (2010) 1.23
MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One (2013) 1.23
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila) (2010) 1.22
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21
Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem (2014) 1.21
Cerebral glucose metabolism associated with a fear network in panic disorder. Neuroreport (2005) 1.20
Syringomyelia without hindbrain herniation: tight cisterna magna. Report of four cases and a review of the literature. J Neurosurg (2002) 1.20
Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One (2013) 1.19
Characteristics of distal posteroinferior cerebellar artery aneurysms. Neurosurgery (2003) 1.19
Natural course of myopic traction maculopathy and factors associated with progression or resolution. Am J Ophthalmol (2013) 1.18
Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology (2008) 1.18
Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer. Carcinogenesis (2002) 1.18
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One (2013) 1.16
Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol (2010) 1.16
miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res (2012) 1.16
Encapsulation of concentrated hemoglobin solution in phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier. J Biol Chem (2007) 1.15
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells. Neuro Oncol (2010) 1.15
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res (2005) 1.14
Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer (2006) 1.11
MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One (2012) 1.11
CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res (2007) 1.11
Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta (2006) 1.10
Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One (2012) 1.09
FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Stem Cells (2011) 1.09
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res (2010) 1.08
Sentinel node mapping guided by indocyanine green fluorescence imaging during laparoscopic surgery in gastric cancer. Ann Surg Oncol (2010) 1.08
Symmetric dumbbell ganglioneuromas of bilateral C2 and C3 roots with intradural extension associated with von Recklinghausen's disease: case report. Surg Neurol (2004) 1.07
MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis (2011) 1.06
Mechanism of ATP-induced local and conducted vasomotor responses in isolated rat cerebral penetrating arterioles. J Vasc Res (2008) 1.05
Conserved structural determinants in three-fingered protein domains. FEBS J (2008) 1.05
Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One (2012) 1.05
Ruptured distal middle cerebral artery aneurysm. J Neurosurg (2004) 1.05
Distribution and variation of bacitracin synthetase gene sequences in laboratory stock strains of Bacillus licheniformis. Curr Microbiol (2002) 1.03
DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer (2008) 1.03
Double-insurance bypass for internal carotid artery aneurysm surgery. Neurosurgery (2003) 1.03
Mechanism of extracellular K+-induced local and conducted responses in cerebral penetrating arterioles. Stroke (2002) 1.02
Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage (2006) 1.02
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res (2007) 1.01
Safe and minimally invasive laminoplastic laminotomy using an ultrasonic bone curette for spinal surgery: technical note. Surg Neurol (2009) 1.01
Standard and limitation of intraoperative monitoring of the visual evoked potential. Acta Neurochir (Wien) (2010) 1.01
Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res (2009) 1.01
Emergency EC-IC bypass for symptomatic atherosclerotic ischemic stroke. Neurosurg Rev (2013) 1.01
Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology. Int J Clin Oncol (2010) 1.00
Posterior auricular artery-middle cerebral artery bypass for additional surgery of moyamoya disease. Acta Neurochir (Wien) (2011) 1.00
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer (2005) 1.00
Transient cerebellar mutism caused by bilateral damage to the dentate nuclei after the second posterior fossa surgery. Case report. J Neurosurg (2006) 1.00
Error-related negativity reflects detection of negative reward prediction error. Neuroreport (2004) 1.00
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res (2012) 1.00
Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol (2005) 0.99
NeuRobot: telecontrolled micromanipulator system for minimally invasive microneurosurgery-preliminary results. Neurosurgery (2002) 0.99
Crossmodal effect with rubber hand illusion and gamma-band activity. Psychophysiology (2007) 0.99
[Current state of measures to deal with natural disasters at public universities]. Nihon Koshu Eisei Zasshi (2012) 0.99
Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol (2002) 0.98
Distinct development and functions of resident and recruited liver Kupffer cells/macrophages. J Leukoc Biol (2013) 0.98
Clip blade scissoring with titanium bayonet clip in aneurysm surgery. Two case reports. Neurol Med Chir (Tokyo) (2012) 0.97